Keeping Track: New Uses For Opdivo, Trodelvy; Nextstellis Introduces A Novel Estrogen

The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker

Keeping Track Feature image

Oncology approvals (and the undoing of an accelerated approval) and the US Food and Drug Administration clearance of a rare new molecular entity in hormonal contraception stood out in a week notably lacking in submission news.

Mayne Pharma USA and Mithra Pharmaceuticals SA’s Nextstellis combines a novel estrogen component – estetrol, or E4 –...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA Performance Tracker

More from Regulatory Trackers